
Textbook of Drug Design and Discovery, Fourth Edition
CRC Press
4th Edition
Published on 1. October 2009
Book
Hardback
476 pages
978-1-4200-6322-6 (ISBN)
Article exhausted; check for reprint
Description
The molecular biological revolution and the mapping of the human genome continue to provide new challenges and opportunities for drug research and design. Future medicinal chemists and drug designers must have a firm background in a number of related scientific disciplines in order to understand the conversion of new insight into lead structures and subsequently into drug candidates. Classroom tested and student approved, Textbook of Drug Design and Discovery, Fourth Edition describes the manner in which medicinal chemists utilize the various fields upon which they draw and the specific strategies they employ to advance promising molecules into clinical use for the treatment of disease.
This text integrates a number of related scientific disciplines, including advanced synthetic chemistry, computational chemistry, biochemistry, structural biology, and molecular pharmacology, to provide current and comprehensive information on all aspects of drug design and discovery.
Extensively revised, new topics in the fourth edition include:
Biostructure-based and ligand-based drug design
Chemical biology
Natural products
Imaging
Neurotransmitter transporters
Opioid and cannabinoid receptors
Hypnotics
Neglected diseases
Immunomodulating agents
Antibiotics
?
The first part of the book covers general aspects, methods, and principles for drug design and discovery, and the second part covers specific targets and diseases. The text contains more than 300 color figures and 24 tables for rapid assimilation. Each chapter includes references for further study. Most chapters also provide the background and history needed to provide a context for students, as well as conclusions that summarize the points most relevant to emerging areas of research in drug design.
This text integrates a number of related scientific disciplines, including advanced synthetic chemistry, computational chemistry, biochemistry, structural biology, and molecular pharmacology, to provide current and comprehensive information on all aspects of drug design and discovery.
Extensively revised, new topics in the fourth edition include:
Biostructure-based and ligand-based drug design
Chemical biology
Natural products
Imaging
Neurotransmitter transporters
Opioid and cannabinoid receptors
Hypnotics
Neglected diseases
Immunomodulating agents
Antibiotics
?
The first part of the book covers general aspects, methods, and principles for drug design and discovery, and the second part covers specific targets and diseases. The text contains more than 300 color figures and 24 tables for rapid assimilation. Each chapter includes references for further study. Most chapters also provide the background and history needed to provide a context for students, as well as conclusions that summarize the points most relevant to emerging areas of research in drug design.
Reviews / Votes
"... figures are relevant and helpful in explaining concepts in the text. The level of detail in the contents of the book makes it especially suitable for academics and advanced students of medicinal chemistry, but may also be of interest to molecular pharmacologists. biochemists, and others of related disciplines."-Chromatographia
More details
Edition
4th New edition
Language
English
Place of publication
Bosa Roca
United States
Publishing group
Taylor & Francis Inc
Target group
College/higher education
Edition type
New edition
Product notice
Paper over boards
Illustrations
24 s/w Tabellen, 338 farbige Abbildungen
28; 24 Tables, black and white; 338 Illustrations, color
Dimensions
Height: 254 mm
Width: 178 mm
Weight
1315 gr
ISBN-13
978-1-4200-6322-6 (9781420063226)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions

Kristian Stromgaard | Povl Krogsgaard-Larsen | Ulf Madsen
Textbook of Drug Design and Discovery
Book
08/2016
5th Edition
CRC Press
€218.40
Shipment within 15-20 days
Additional editions

Kristian Stromgaard | Povl Krogsgaard-Larsen | Ulf Madsen
Textbook of Drug Design and Discovery
E-Book
10/2009
4th Edition
CRC Press
€83.99
Available for download
Ulf Madsen | Povl Krogsgaard-Larsen | Kristian Stromgaard
Textbook of Drug Design and Discovery, Fourth Edition
Loose-leaf edition
03/2009
4th Edition
CRC Press
€93.55
Article exhausted; check different version
Previous edition
Tommy Liljefors | Povl Krogsgaard-Larsen | Ulf Madsen
Textbook of Drug Design and Discovery, Third Edition
Book
08/2002
3rd Edition
Taylor & Francis
€135.19
Article exhausted; check for reprint
Persons
Povl Krogsgaard-Larsen is a professor of medicinal chemistry in the Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, at the University of Copenhagen. Kristian Stromgaard is a professor of chemical biology in the Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, at the University of Copenhagen. Ulf Madsen is currently an associate dean in the Faculty of Pharmaceutical Sciences at the University of Copenhagen.
Editor
University of Copenhagen, Denmark
University of Copenhagen, Denmark
University of Copenhagen, Denmark
Content
Introduction to Drug Design and Discovery, P. Krogsgaard-Larsen and L. Bunch
Molecular Recognition in Ligand-Protein Binding, T. Liljefors
Biostructure-Based Drug Design, F. S. Jorgensen and J. S. Kastrup
Ligand-Based Drug Design, I. Pettersson, T. Balle, and T. Liljefors
Chemical Biology, K. Stromgaard
Stereochemistry in Drug Design, M. B. Mayo-Martin and D. E. Jane
Natural Products in Drug Discovery, G. T. Carter
Imaging in Drug Discovery and Development, M. Rudin and T. Mueggler
Peptides and Peptidomimetics, M. Cai, V. V. Kulkarni, and V. J. Hruby
Prodrugs: Design and Development, A. Buur and N. Mork
Metals in Medicine: Inorganic Medicinal Chemistry, H. R. Hansen and O. Farver
Enzyme Inhibitors: Biostructure-Based and Mechanism-Based Designs, R. A. Copeland, R. R. Gontarek, and L. Luo
Receptors: Structure, Function, and Pharmacology, H. Braeuner-Osborne
Ion Channels: Structure and Function, S.-P. Olesen and D. B. Timmermann
Neurotransmitter Transporters: Structure and Function, C. J. Loland and U. Gether
GABA and Glutamic Acid Receptor Ligands, B. Frolund and U. Madsen
Acetylcholine, A. A. Jensen and P. Krogsgaard-Larsen
Histamine Receptors, I. de Esch, H. Timmerman, and R. Leurs
Dopamine and Serotonin, B. Bang-Andersen and K. P. Bogeso
Opioid and Cannabinoid Receptors, R. P. Clausen and H. S. Hansen
Hypnotics, B. Ebert and K. A. Wafford
Neglected Diseases, S. B. Christensen
Immunomodulating Agents, U. G. Sidelmann
Anticancer Agents, F. Bjoerkling and L. H. Jensen
Antiviral Drugs, E. De Clercq
Antibiotics, P. Herdewijn
Index
Molecular Recognition in Ligand-Protein Binding, T. Liljefors
Biostructure-Based Drug Design, F. S. Jorgensen and J. S. Kastrup
Ligand-Based Drug Design, I. Pettersson, T. Balle, and T. Liljefors
Chemical Biology, K. Stromgaard
Stereochemistry in Drug Design, M. B. Mayo-Martin and D. E. Jane
Natural Products in Drug Discovery, G. T. Carter
Imaging in Drug Discovery and Development, M. Rudin and T. Mueggler
Peptides and Peptidomimetics, M. Cai, V. V. Kulkarni, and V. J. Hruby
Prodrugs: Design and Development, A. Buur and N. Mork
Metals in Medicine: Inorganic Medicinal Chemistry, H. R. Hansen and O. Farver
Enzyme Inhibitors: Biostructure-Based and Mechanism-Based Designs, R. A. Copeland, R. R. Gontarek, and L. Luo
Receptors: Structure, Function, and Pharmacology, H. Braeuner-Osborne
Ion Channels: Structure and Function, S.-P. Olesen and D. B. Timmermann
Neurotransmitter Transporters: Structure and Function, C. J. Loland and U. Gether
GABA and Glutamic Acid Receptor Ligands, B. Frolund and U. Madsen
Acetylcholine, A. A. Jensen and P. Krogsgaard-Larsen
Histamine Receptors, I. de Esch, H. Timmerman, and R. Leurs
Dopamine and Serotonin, B. Bang-Andersen and K. P. Bogeso
Opioid and Cannabinoid Receptors, R. P. Clausen and H. S. Hansen
Hypnotics, B. Ebert and K. A. Wafford
Neglected Diseases, S. B. Christensen
Immunomodulating Agents, U. G. Sidelmann
Anticancer Agents, F. Bjoerkling and L. H. Jensen
Antiviral Drugs, E. De Clercq
Antibiotics, P. Herdewijn
Index